Lataa...
NEW EXPERIMENTAL MODELS FOR AROMATASE INHIBITOR RESISTANCE
Clinical trials have demonstrated the importance of aromatase inhibitor (AI) therapy in the effective treatment of hormone-dependent breast cancers. In contrast to tamoxifen, an antagonist of the estrogen receptor (ER), AIs have shown to be better tolerated along with decreased recurrence rates of t...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2743954/ https://ncbi.nlm.nih.gov/pubmed/17611102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsbmb.2007.05.020 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|